TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
SRZN

Surrozen Inc

Healthcare · Biotechnology

17.60$ +6.5% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow SRZN
Line item 2019 2020 2021 2022 2023 2024 2025
-353.2% -322.9% -165.4% -869.8%
15.6% 15.3% 13.5% 15.4%
36.1% 35.0% 38.6% 110.3%
-67.3% -31.4% -7.8% 90.7%
5.8% 3.2% 0.2% 3.7%
306.5% 413.8% -0.2% -3.7%
-20.9% 0.0% 0.9% 5.7%
-20.5% 2.2% 151.8% 2,446.1%
-67.2% 93.1% -13.9% 1,572.6%
-359.0% -326.1% -165.7% -873.5%

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?